Sixty two tissue samples from prostate cancer patients with diverse clinical stages were collected and semi-quantitative immunohistochemical staining using antibodies against NCoR Ser (P)-2436 and IP-10 was performed (Fig. 5A). Here, CXCL10 is linked to prostate cancer.